Genomictree Inc. (228760.KQ)

KRW 23550.0

(3.06%)

Total Assets Summary of Genomictree Inc.

  • Genomictree Inc.'s latest annual total assets in 2023 was 132.84 Billion KRW , down -18.46% from previous year.
  • Genomictree Inc.'s latest quarterly total assets in 2024 Q2 was 136.89 Billion KRW , up 3.92% from previous quarter.
  • Genomictree Inc. reported annual total assets of 162.9 Billion KRW in 2022, down -8.04% from previous year.
  • Genomictree Inc. reported annual total assets of 177.15 Billion KRW in 2021, up 50.26% from previous year.
  • Genomictree Inc. reported quarterly total assets of 131.73 Billion KRW for 2024 Q1, down -0.83% from previous quarter.
  • Genomictree Inc. reported quarterly total assets of 132.84 Billion KRW for 2023 Q4, down -3.48% from previous quarter.

Annual Total Assets Chart of Genomictree Inc. (2023 - 2016)

Historical Annual Total Assets of Genomictree Inc. (2023 - 2016)

Year Total Assets Total Assets Growth
2023 132.84 Billion KRW -18.46%
2022 162.9 Billion KRW -8.04%
2021 177.15 Billion KRW 50.26%
2020 117.89 Billion KRW 3.67%
2019 113.72 Billion KRW 715.02%
2018 13.95 Billion KRW 34.36%
2017 10.38 Billion KRW 88.76%
2016 5.5 Billion KRW 0.0%

Peer Total Assets Comparison of Genomictree Inc.

Name Total Assets Total Assets Difference
HLB Co., Ltd. 751.72 Billion KRW 82.328%
iNtRON Biotechnology, Inc. 98.61 Billion KRW -34.71%
BINEX Co., Ltd. 257.01 Billion KRW 48.312%
Bioneer Corporation 315.48 Billion KRW 57.892%
Anterogen.Co.,Ltd. 149.43 Billion KRW 11.1%
MEDIPOST Co., Ltd. 449.39 Billion KRW 70.439%
CrystalGenomics, Inc. 243.11 Billion USD 45.358%
Helixmith Co., Ltd 227.27 Billion KRW 41.55%
Chabiotech Co.,Ltd. 1725.57 Billion KRW 92.301%
Medy-Tox Inc. 611.62 Billion KRW 78.28%
Peptron, Inc. 52.49 Billion KRW -153.056%
Amicogen, Inc. 467.09 Billion KRW 71.56%
Genexine, Inc. 376.58 Billion KRW 64.724%
HLB Therapeutics Co.,Ltd. 200.79 Billion KRW 33.841%
LegoChem Biosciences, Inc. 189.5 Billion KRW 29.898%
ALTEOGEN Inc. 256.09 Billion KRW 48.128%
PharmaResearch Co., Ltd. 535.28 Billion KRW 75.182%
SillaJen, Inc. 76.71 Billion KRW -73.166%
JETEMA, Co., Ltd. 252.14 Billion KRW 47.315%
OliX Pharmaceuticals,Inc 102.82 Billion KRW -29.194%
MedPacto, Inc. 80.47 Billion KRW -65.076%
D&D Pharmatech 79.2 Billion KRW -67.725%
EASY BIO,Inc. 172.04 Billion KRW 22.784%
GI Innovation, Inc. 81.34 Billion KRW -63.319%